A U.S. Air Force study found that only about 3% of pilots fell within the middle 30 percentiles on just three body measurements simultaneously, meaning cockpits designed for the 'average pilot' were actually designed for almost no one.
Snapshot · Modern Wisdom
A U.S. Air Force study found that only about 3% of pilots fell within the middle 30 percentiles on just three body measurements simultaneously, meaning cockpits designed for the 'average pilot' were actually designed for almost no one.
Where this was said
At 1:00:00 · chapter starts 56:45
Epstein extends the constraints argument into design philosophy, exploring universal design — the principle that building for the most constrained user reveals failure modes that affect far more of the user population than anyone initially realised. Curb cuts were made for wheelchairs but turned out better for everyone; hierarchical website menus emerged from screen-reader requirements for the visually impaired but improved navigation for all users. The most vivid example is military body armour: after decades of soldiers being turned into immobile turtles by increasingly heavy armour optimised purely for ballistic protection, the integration of women into close combat roles for the first time required designing lighter, more mobile, modular armour with a notch for a hair bun. The notch turned out to be what every soldier wanted for raising their head in a prone position. The armour was so popular with male soldiers that the Army had to rebrand it as 'unisex' simply to give men permission to use it. The F-16 cockpit story is an adjacent example: a lieutenant's study found that only 3% of pilots fell within the middle 30 percentiles on just three body measurements simultaneously, revealing that 'average' cockpits fit almost no one and that adjustable cockpits dramatically reduced accident rates.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.